Skip to main content
. 2017;18(8):2275–2285. doi: 10.22034/APJCP.2017.18.8.2275

Figure 3.

Figure 3

CTC Monitoring of a) cancer patients (group1) and b) asymptomatic patients without detectable tumour (group3) before and after integrative therapies including immune-stimulating nutrients. Cancer patients (group 1) with mild disease did not undergo surgery, chemo- or radiotherapy due to variety of reasons.